(Q39177080)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28290049%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

title

Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28290049%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28290049%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Christopher D Byrne

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28290049%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

author name string

P Wainwright

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28290049%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

publication date

1 April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28290049%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

published in

Current diabetes report

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28290049%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28290049%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28290049%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

page(s)

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28290049%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11892-017-0851-x

5 April 2020

exact match

0 references

cites work

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Hepatocellular carcinoma in the Asia pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Obesity and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Abdominal obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Nonalcoholic fatty liver disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Nonalcoholic fatty liver disease and hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

PNPLA3 I148M polymorphism and progressive liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

PNPLA3/adiponutrin functions in lipid droplet formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Inflammatory links between obesity and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

The complexity of NF-κB signaling in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Mitochondrial adaptations to obesity-related oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

The lipid peroxidation product 4-hydroxy-2-nonenal: Advances in chemistry and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

A central role for JNK in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Survival and causes of death in hemochromatosis. Observations in 163 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Nonalcoholic fatty liver disease and mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Type 2 diabetes mellitus and the risk of hepatitis C virus infection: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-017-0851-X

Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis

21 January 2018

1 reference

12 December 2020

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

1 reference

12 December 2020

JNK1, a potential therapeutic target for hepatocellular carcinoma

1 reference

12 December 2020

Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation

1 reference

12 December 2020

Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis

1 reference

12 December 2020

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

1 reference

12 December 2020

Diabetes and Hepatitis C: A Two-Way Association

1 reference

12 December 2020

10.1007/S11892-017-0851-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28290049%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference